SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-13-003202
Filing Date
2013-06-04
Accepted
2013-06-04 19:26:00
Documents
1
Period of Report
2013-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-17317.html 4  
1 PRIMARY DOCUMENT marketforms-17317.xml 4 3117
  Complete submission text file 0001214659-13-003202.txt   4558
Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
DZIURZYNSKI BOGDAN (Reporting) CIK: 0001248147 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 13892839

Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences